Improved quality of care for patients infected or colonised with ESBL-producing Enterobacteriaceae in a French teaching hospital: impact of an interventional prospective study and development of specific tools
The increasing incidence of ESBL-producing Enterobacteriaceae (ESBL-E) in France prompted the publication of national recommendations in 2010. Based on these, we developed a toolkit and a warning system to optimise management of ESBL-E infected or colonised patients in both community and hospital settings. The impact of this initiative on quality of care was assessed in a teaching hospital. The ESBL toolkit was developed in 2011 during multidisciplinary meetings involving a regional network of hospital, private clinic and laboratory staff in Southeastern France. It includes antibiotic treatment protocols, a check list, mail templates and a patient information sheet focusing on infection control. Upon identification of ESBL-E, the warning system involves alerting the attending physician and the infectious disease (ID) advisor, with immediate, advice-based implementation of the toolkit. The procedure and toolkit were tested in our teaching hospital. Patient management was compared before and after implementation of the toolkit over two 3-month periods (July–October 2010 and 2012). Implementation of the ESBL-E warning system and ESBL-E toolkit was tested for 87 patients in 2010 and 92 patients in 2012, resulting in improved patient management: expert advice sought and followed (16 vs 97%), information provided to the patient’s general practitioner (18 vs 63%) and coding of the condition in the patient’s medical file (17 vs 59%), respectively. Our multidisciplinary strategy improved quality of care for in-patients infected or colonised with ESBL-E, increasing compliance with national recommendations.
We thank Brigitte Dunais for her assistance in preparing this manuscript.
- 1.Birgand G, Johansson A, Szilagyi E, Lucet JC (2015) Overcoming the obstacles of implementing infection prevention and control guidelines. Clin Microbiol Infect. https://doi.org/10.1016/j.cmi2015.09.005
- 2.Point prevalence survey of health care associated infections and antimicrobial use 2011-2012: http://ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf
- 3.Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C (2017) BacterCom Study Group. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents 49(1):67–73. https://doi.org/10.1016/j.ijantimicag.2016.09.032 CrossRefPubMedGoogle Scholar
- 4.Löhr IH, Rettedal S, Natås OB, Naseer U, Oymar K, Sundsfjord A (2013) Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother 68(5):1043–1048. https://doi.org/10.1093/jac/dks502 CrossRefPubMedGoogle Scholar
- 5.Nielsen MV, Sarpong N, Krumkamp R, Dekker D, Loag W, Amemasor S, Agyekum A, Marks F, Huenger F, Krefis AC, Hagen RM, Adu-Sarkodie Y, May J, Schwarz NG (2012) Incidence and characteristics of bacteremia among children in rural Ghana. PLoS One 7(9):e44063. https://doi.org/10.1371/journal.pone.0044063 CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Ho C, Lau A, Cimon K, Farrah K, Gardam M (2012) Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum beta-lactamase producing organisms: a systematic review of the clinical evidence and health services impact [Internet]. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON) CADTH Rapid Response ReportsGoogle Scholar
- 10.Arnaud I, Maugat S, Jarlier V, Astagneau P (2015) National Early Warning; Investigation and Surveillance of Healthcare-Associated Infections Network (RAISIN)/multidrug resistance study group. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013. Euro Surveill 20(36). https://doi.org/10.2807/1560-7917.ES.2015.20.36.30014.
- 11.De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, Carmeli Y, Tacconelli E (2014) Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother 69(5):1185–1192. https://doi.org/10.1093/jac/dkt525 CrossRefPubMedGoogle Scholar
- 13.Maslikowska JA, Walker SA, Mittmann N, Palmay L, Daneman N, Simor A (2016) Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect 92(1):33–41. https://doi.org/10.1016/j.jhin.2015.10.001 CrossRefPubMedGoogle Scholar